Ocrelizumab in the Treatment of Primary-Progressive Multiple Sclerosis

Medical Council
doi 10.21518/2079-701x-2018-1-77-78
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Remedium, Ltd.

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy